Key result
VDAC3 knockdown or Mito-TEMPO suppresses enteroviral replication by reducing mitochondrial ROS generation.
Why the study?
EV71 has caused outbreaks in China and Southeast Asia and induces reactive oxygen species, but the underlying mechanism remains elusive.
The study demonstrates that Enterovirus 71 2B protein interacts with host VDAC3 to enhance mitochondrial ROS generation, suggesting antioxidant pathways as potential therapeutic targets for viral inhibition.
Mito-TEMPO or VDAC3 knockdown inhibited EV71 replication in vitro; hypothesis-generating for mitochondrial antioxidants in enterovirus, without clinical implications yet.
Enterovirus (EV) 71 caused episodes of outbreaks in China and Southeast Asia during the last few decades. We have previously reported that EV71 induces reactive oxygen species (ROS). However, the underlying mechanism remains elusive. Co-immunoprecipitation-proteomic analysis revealed that enteroviral 2B protein interacted with mitochondrial voltage-dependent anion channel 3 (VDAC3). Knockdown (KD) of VDAC3 expression specifically inhibited enteroviral replication. Single-round viral replication was also inhibited in KD cells, suggesting that VDAC3 plays an essential role in replication. Consistent with this, VDAC3 gene KD significantly reduced the EV71-induced mitochondrial ROS generation. Exogenous 2B expression could induce the mitochondrial ROS generation that was significantly reduced in VDAC3-KD cells or in the Mito-TEMPO-treated cells. Moreover, VDAC3 appears to be necessary for regulation of antioxidant metabolism. VDAC3 gene KD led to the enhancement of such pathways as hypotaurine/taurine synthesis in the infected cells. Taken together, these findings suggest that 2B and VDAC3 interact to enhance mitochondrial ROS generation, which promotes viral replication.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2022) studied Enterovirus 71 infection. VDAC3 knockdown or Mito-TEMPO treatment vs. Non-target control or mock treatment was evaluated on Enteroviral replication (titer and genomic RNA) and mitochondrial ROS generation. Knockdown of VDAC3 or treatment with the antioxidant Mito-TEMPO reduced EV71-induced mitochondrial ROS generation and significantly inhibited enteroviral replication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: